BioWorld Nov 24, 2025 Novo’s semaglutide fails in phase III Alzheimer’s trials #phase III #III Alzheimer
BioWorld Nov 24, 2025 Data back spinal injury bid from Nervgen in phase Ib/IIa #Pharma Corp #Nervgen Pharma
BioWorld Nov 24, 2025 CMS finalizes plan to do away with inpatient-only list #Medicaid Services #CMS finalizes
BioWorld Nov 24, 2025 New Samyang Holdings, Samsung Biologics spin-offs debut on Kospi #Samyang Holdings #Samsung Biologics
BioWorld Nov 24, 2025 Diag-nose.io develops respiratory disease precision diagnostics #Medical Pty #Diag-Nose Medical
BioWorld Nov 24, 2025 Appointments and advancements for Nov. 24, 2025 #Galvanize Therapeutics #med-tech industry
BioWorld Nov 24, 2025 Abbott mum on malfunction behind Freestyle Libre 3 recall #Freestyle Libre #Abbott Laboratories
BioWorld Nov 24, 2025 CMR Surgical targets US with Versius Plus robotic system #CMR Surgical #Surgical targets